S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
NASDAQ:AQB

AquaBounty Technologies Stock Forecast, Price & News

$7.74
+0.37 (+5.02 %)
(As of 02/24/2021 05:16 PM ET)
Add
Compare
Today's Range
$7.17
Now: $7.74▼
$7.89
50-Day Range
$7.94
MA: $9.91▼
$12.20
52-Week Range
$1.59
Now: $7.74▼
$13.32
Volume1.77 million shs
Average Volume3.92 million shs
Market Capitalization$545.26 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27
AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts.
AquaBounty Technologies logo

Headlines

AquaBounty Technologies, Inc. Announces Closing of $127.1 Million Public Offering of Common Stock, Including Full Exercise of Overallotment Option
February 8, 2021 |  finance.yahoo.com
Why AquaBounty Technologies Stock Plunged Today
February 4, 2021 |  finance.yahoo.com
AquaBounty Technologies, Inc. Announces Pricing of $110.5 Million Public Offering of Common Stock
February 4, 2021 |  finance.yahoo.com
Here's Why AquaBounty Technologies Stock Went Up 14% in January
February 2, 2021 |  finance.yahoo.com
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AquaBounty Technologies, Inc.- AQB
February 2, 2021 |  finance.yahoo.com
Insider Buying: The AquaBounty Technologies, Inc. (NASDAQ:AQB) Independent Non-Executive Director Just Bought 16% More Shares
December 20, 2020 |  finance.yahoo.com
AquaBounty Technologies, Inc. Announces Closing of $65.2 Million Upsized Public Offering of Common Stock, Including Full Exercise of Overallotment Option
December 14, 2020 |  finance.yahoo.com
Why AquaBounty Stock Was Falling Today After More Than Doubling in Two Weeks
December 10, 2020 |  finance.yahoo.com
AquaBounty Technologies Provides Corporate Update
December 9, 2020 |  finance.yahoo.com
Earnings Update: Here's Why Analysts Just Lifted Their AquaBounty Technologies, Inc. (NASDAQ:AQB) Price Target To US$4.83
November 6, 2020 |  finance.yahoo.com
Is AquaBounty Technologies (NASDAQ:AQB) Using Too Much Debt?
November 5, 2020 |  finance.yahoo.com
AquaBounty Technologies, Inc. Announces Results for the Quarter and Nine Months Ended September 30, 2020 and Provides a Corporate Update
November 3, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Fishing, hunting & trapping
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AQB
Previous Symbol
CUSIPN/A
CIK1603978
Webwww.aquabounty.com
Phone978-648-6000
Employees71
Year FoundedN/A

Debt

Debt-to-Equity Ratio0.14
Current Ratio18.33
Quick Ratio17.10

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$190,000.00
Price / Sales2,869.79
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.10 per share
Price / Book7.04

Profitability

EPS (Most Recent Fiscal Year)($0.66)
Net Income$-13,230,000.00
Net Margins-11,050.81%
Return on Equity-36.77%
Return on Assets-30.50%

Miscellaneous

Outstanding Shares70,447,000
Market Cap$545.26 million
Next Earnings Date3/9/2021 (Estimated)
OptionableNot Optionable

MarketRank™

Overall MarketRank™

1.43 out of 5 stars

Medical Sector

517th out of 1,958 stocks

Fishing, Hunting & Trapping Industry

1st out of 5 stocks

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
$7.74
+0.37 (+5.02 %)
(As of 02/24/2021 05:16 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AquaBounty Technologies (NASDAQ:AQB) Frequently Asked Questions

Is AquaBounty Technologies a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AquaBounty Technologies stock.
View analyst ratings for AquaBounty Technologies or view top-rated stocks.

What stocks does MarketBeat like better than AquaBounty Technologies?

Wall Street analysts have given AquaBounty Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AquaBounty Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AquaBounty Technologies?

AquaBounty Technologies saw a decrease in short interest in the month of January. As of January 29th, there was short interest totaling 1,080,000 shares, a decrease of 28.0% from the January 14th total of 1,500,000 shares. Based on an average daily volume of 4,190,000 shares, the short-interest ratio is currently 0.3 days.
View AquaBounty Technologies' Short Interest.

When is AquaBounty Technologies' next earnings date?

AquaBounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for AquaBounty Technologies.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) issued its quarterly earnings results on Tuesday, November, 3rd. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.08) by $0.01. The company had revenue of $0.07 million for the quarter, compared to analyst estimates of $1.79 million. AquaBounty Technologies had a negative trailing twelve-month return on equity of 36.77% and a negative net margin of 11,050.81%.
View AquaBounty Technologies' earnings history.

How has AquaBounty Technologies' stock price been impacted by Coronavirus (COVID-19)?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AQB stock has increased by 318.4% and is now trading at $7.74.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for AQB?

3 analysts have issued 12-month price objectives for AquaBounty Technologies' stock. Their forecasts range from $3.50 to $9.00. On average, they expect AquaBounty Technologies' stock price to reach $5.83 in the next year. This suggests that the stock has a possible downside of 24.6%.
View analysts' price targets for AquaBounty Technologies or view top-rated stocks among Wall Street analysts.

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:
  • Ms. Sylvia A. Wulf, CEO, Pres & Exec. Director (Age 63, Pay $383.17k)
  • Mr. David A. Frank, CFO & Treasurer (Age 61, Pay $282.8k)
  • Dr. Alejandro Rojas, Chief Operating Officer of AquaBounty Farms (Age 59, Pay $234.1k)
  • Dr. Mark Walton, Chief Technology Officer
  • Ms. Angela M. Olsen J.D., Gen. Counsel & Corp. Sec. (Age 52)
  • Dave Conley, Director of Communications
  • Mr. David F. Melbourne Jr., Chief Commercial Officer
  • Mr. Louis H. Barnett, Financial Advisor

Who are some of AquaBounty Technologies' key competitors?

Some companies that are related to AquaBounty Technologies include ModivCare (MODV), Applied Molecular Transport (AMTI), Health Catalyst (HCAT), Myovant Sciences (MYOV), Dicerna Pharmaceuticals (DRNA), Stoke Therapeutics (STOK), ADC Therapeutics (ADCT), MEDNAX (MD), Surgery Partners (SGRY), Sundial Growers (SNDL), Pulmonx (LUNG), USANA Health Sciences (USNA), NGM Biopharmaceuticals (NGM), Praxis Precision Medicines (PRAX) and UDG Healthcare (UDG).
View all of AQB's competitors.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Aurora Cannabis (ACB), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the NASDAQ under the ticker symbol "AQB."

Who are AquaBounty Technologies' major shareholders?

AquaBounty Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Third Security LLC (25.86%), Epiq Partners LLC (1.46%), Sumitomo Mitsui Trust Holdings Inc. (0.35%), Nikko Asset Management Americas Inc. (0.28%), Capital Impact Advisors LLC (0.27%) and Voloridge Investment Management LLC (0.10%). Company insiders that own AquaBounty Technologies stock include David A Frank, Randal J Kirk, Richard L Huber and Rick L Sterling.
View institutional ownership trends for AquaBounty Technologies.

Which major investors are selling AquaBounty Technologies stock?

AQB stock was sold by a variety of institutional investors in the last quarter, including HighTower Advisors LLC, Epiq Partners LLC, Third Security LLC, Winthrop Advisory Group LLC, Cambridge Investment Research Advisors Inc., and KBC Group NV.
View insider buying and selling activity for AquaBounty Technologies or view top insider-selling stocks.

Which major investors are buying AquaBounty Technologies stock?

AQB stock was purchased by a variety of institutional investors in the last quarter, including Capital Impact Advisors LLC, Voloridge Investment Management LLC, Price T Rowe Associates Inc. MD, Citigroup Inc., Bank of New York Mellon Corp, Exencial Wealth Advisors LLC, Wells Fargo & Company MN, and Nikko Asset Management Americas Inc.. Company insiders that have bought AquaBounty Technologies stock in the last two years include David A Frank, Randal J Kirk, Richard L Huber, and Rick L Sterling.
View insider buying and selling activity for AquaBounty Technologies or or view top insider-buying stocks.

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $7.74.

How much money does AquaBounty Technologies make?

AquaBounty Technologies has a market capitalization of $545.26 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis.

How many employees does AquaBounty Technologies have?

AquaBounty Technologies employs 71 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is www.aquabounty.com.

Where are AquaBounty Technologies' headquarters?

AquaBounty Technologies is headquartered at 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754.

How can I contact AquaBounty Technologies?

AquaBounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected]


This page was last updated on 2/24/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.